Pamela S. Herrera

944 total citations · 1 hit paper
8 papers, 411 citations indexed

About

Pamela S. Herrera is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Pamela S. Herrera has authored 8 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Pamela S. Herrera's work include CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Genomics and Rare Diseases (1 paper). Pamela S. Herrera is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Genomics and Rare Diseases (1 paper). Pamela S. Herrera collaborates with scholars based in United States. Pamela S. Herrera's co-authors include Marcel R.M. van den Brink, Kathryn E. Yost, Bryan H. King, Ansuman T. Satpathy, Mirela Berisa, Daniel K. Wells, Craig B. Thompson, Justin R. Cross, Santosha A. Vardhana and Melody Smith and has published in prestigious journals such as Blood, Nature Immunology and Scientific Reports.

In The Last Decade

Pamela S. Herrera

8 papers receiving 406 citations

Hit Papers

Impaired mitochondrial ox... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela S. Herrera United States 3 226 166 161 65 40 8 411
Florian Wanke Germany 12 242 1.1× 74 0.4× 139 0.9× 27 0.4× 25 0.6× 20 387
Anna A. Kudriaeva Russia 13 113 0.5× 90 0.5× 244 1.5× 27 0.4× 23 0.6× 41 373
Livingstone Fultang United Kingdom 7 219 1.0× 216 1.3× 153 1.0× 93 1.4× 58 1.4× 8 458
Alex Ray United States 12 203 0.9× 152 0.9× 210 1.3× 45 0.7× 47 1.2× 21 510
Gang Xiao United States 12 270 1.2× 176 1.1× 227 1.4× 58 0.9× 41 1.0× 33 557
Madeline A. Hwee United States 3 330 1.5× 292 1.8× 217 1.3× 72 1.1× 44 1.1× 4 577
Céline Yacoub Maroun Switzerland 7 205 0.9× 153 0.9× 121 0.8× 56 0.9× 28 0.7× 8 338
Bruno Giotti United States 7 140 0.6× 62 0.4× 151 0.9× 62 1.0× 14 0.3× 12 331
Andreas Warnecke Sweden 7 228 1.0× 62 0.4× 122 0.8× 21 0.3× 16 0.4× 8 399
Sunny Mai United States 7 211 0.9× 93 0.6× 101 0.6× 35 0.5× 10 0.3× 8 322

Countries citing papers authored by Pamela S. Herrera

Since Specialization
Citations

This map shows the geographic impact of Pamela S. Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela S. Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela S. Herrera more than expected).

Fields of papers citing papers by Pamela S. Herrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela S. Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela S. Herrera. The network helps show where Pamela S. Herrera may publish in the future.

Co-authorship network of co-authors of Pamela S. Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela S. Herrera. A scholar is included among the top collaborators of Pamela S. Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela S. Herrera. Pamela S. Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Herrera, Pamela S. & Marcel R.M. van den Brink. (2024). The Intestinal Microbiota and Therapeutic Responses to Immunotherapy. 8(1). 435–452. 2 indexed citations
2.
Turner, Robert, et al.. (2023). Prevalence of p.G87V and p.Gln298=Variations in LIPA Gene Within Middle Eastern Population Living Around Los Angeles. Genetic Testing and Molecular Biomarkers. 27(10). 319–324. 1 indexed citations
3.
Lee, Nicole, Gabriel K. Armijo, Pamela S. Herrera, et al.. (2021). Highly Selective Irreversible ITK Inhibitor Cpi-818 Reduces Acute Graft-Versus Host Disease. Blood. 138(Supplement 1). 3814–3814. 1 indexed citations
4.
Vardhana, Santosha A., Madeline A. Hwee, Mirela Berisa, et al.. (2020). Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nature Immunology. 21(9). 1022–1033. 343 indexed citations breakdown →
5.
Vasireddy, Vidyullatha, Pamela S. Herrera, Lanfranco Leo, et al.. (2018). Use of induced pluripotent stem cell models to probe the pathogenesis of Choroideremia and to develop a potential treatment. Stem Cell Research. 27. 140–150. 38 indexed citations
6.
Mills, Jason A., Pamela S. Herrera, Maninder Kaur, et al.. (2018). NIPBL+/− haploinsufficiency reveals a constellation of transcriptome disruptions in the pluripotent and cardiac states. Scientific Reports. 8(1). 1056–1056. 23 indexed citations
7.
Mills, Jason A., Kristin Hudock, Spencer K. Sullivan, et al.. (2015). Generation of poikiloderma with neutropenia (PN) induced pluripotent stem cells (iPSCs). Stem Cell Research. 15(3). 595–597. 1 indexed citations
8.
Herrera, Pamela S., et al.. (2000). Evaluación de un modelo de intervención para fomentar estilos de vida saludables en preescolares. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026